통화 / GUTS
GUTS: Fractyl Health Inc
0.97
USD
0.02
(2.02%)
GUTS 환율이 오늘 -2.02%로 변동했습니다. 당일 이 종목은 저가가 0.96이고 고가는 1.00이었습니다.
Fractyl Health Inc 변동을 참고하세요. 실시간 쿼트는 여러분이 시장 변동에 빠르게 대처하는데에 도움이 될 것입니다. 차트 주기를 전환하여 환율의 추세와 변동을 분, 시간, 일, 주 및 월별로 모니터링할 수 있습니다. 이 정보를 사용하여 시장 변화를 예측하고 정보에 입각한 거래 결정을 내리십시오.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GUTS News
- This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - CoreWeave (NASDAQ:CRWV), Biomea Fusion (NASDAQ:BMEA)
- Canaccord Genuity lowers Fractyl Health stock price target to $6 from $12
- Fractyl Health raises $23 million in public offering with warrants
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19%
- Nasdaq Surges 1%; Uber Sales Top Estimates - Ainos (NASDAQ:AIMD), Astera Labs (NASDAQ:ALAB)
- Fractyl Health stock plunges after $20 million public offering
- US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - Ainos (NASDAQ:AIMD), Fractyl Health (NASDAQ:GUTS)
- Fractyl Health prices $20 million public offering of common stock
- Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Astera Labs (NASDAQ:ALAB), Digital Turbine (NASDAQ:APPS)
- Fractyl Health announces proposed public offering of common stock
- Fractyl’s Revita procedure shows durable weight loss in diabetes patients
- Canaccord Genuity reiterates Buy rating on Fractyl Health stock
- Fractyl Health: Speculative Buy With Binary Risk (NASDAQ:GUTS)
- Fractyl Health stock maintains Buy rating at Canaccord on positive trial data
- Fractyl Health Stock Is Trading Lower Monday: What's Going On? - Fractyl Health (NASDAQ:GUTS)
- Fractyl Health stock steady as Evercore ISI reiterates outperform rating
- Fractyl reports positive 3-month data for post-GLP-1 weight maintenance
- Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type
- Fractyl Health receives two new patents for duodenal resurfacing tech
- Fractyl Health to Present New Preclinical Data from its Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association’s 85th Scientific Sessions
- Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita ® Across its Bariatric and Metabolic Endoscopy Centers Nationwide
- Fractyl Health advances gene therapy for diabetes treatment
- Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
- Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript
일일 변동 비율
0.96
1.00
년간 변동
0.87
3.67
- 이전 종가
- 0.99
- 시가
- 0.99
- Bid
- 0.97
- Ask
- 1.27
- 저가
- 0.96
- 고가
- 1.00
- 볼륨
- 510
- 일일 변동
- -2.02%
- 월 변동
- -47.28%
- 6개월 변동
- -39.38%
- 년간 변동율
- -71.80%
31 8월, 일요일